Correction of Stock Option Grant: Grantees 4→3, Exercise Price 32,600→9,450 Won
-
Correction filing date: 2026.05.14, original filing date: 2020.03.30
-
Grantees: 4→3 (resignation, etc.), granted shares: 11,250→19,500
-
Exercise price: 32,600 won → 9,450 won (adjusted due to capital increase and stock dividends)
-
Total outstanding options after this grant: 1,941,396→4,092,568 (reflecting changes)
-
Fair value calculation: binomial model, only exercise price changed among key assumptions (closing price 34,000 won, risk-free rate 0.838~2.169%, volatility 53.13%)
-
Other terms unchanged (exercise period 2022.03.31~2029.03.30, etc.)
KOSDAQ Filing Information
-
Filing: [Correction of Description] Report on Grant of Stock Options
-
Company: Genome & (314130)
-
Submission: Genome & Company
-
Receipt: 05-14-2026